4 Results for "

BRCA1-IN-2

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "BRCA1-IN-2" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-100862
CAS No.: 1622262-55-8
Purity:  98.04%
Target:  

PARP

Research Areas:  

Cancer

BRCA1-IN-2 (compound 15) is a cell-permeable protein-protein interaction (PPI) inhibitor for BRCA1 with an IC50 of 0.31 μM and a Kd of 0.3 μM, which shows antitumor activities via the disruption of BRCA1 (BRCT)2/protein interactions .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-162706
CAS No.: 2519823-37-9
Target:  

PROTACs CDK

Research Areas:  

Cancer

BSJ-5-63 is a potent CDK12, CDK7, CDK9 PROTAC degrader. BSJ-5-63 BSJ-5-63 decreases the protein expression of CDK12, CDK7, CDK9, RNAPII, Cyclin K. BSJ-5-63 decreases the mRNA expression of BRCA1, BRCA2. BSJ-5-63 shows anticancer activity and has the potential for the research of prostate cancer .
loading...
    loading...
Cat. No.: HY-158346
CAS No.: 2922287-81-6
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

RP-2119 is an orally bioactive Polymerase Theta (Polθ) inhibitor, with an IC50 of 0.7 nM against human Polθ ATPase. RP-2119 reduces Polθ activity and exerts antiproliferative effects in BRCA2-deficient cancer cells. RP-2119 exhibits antitumor activity in BRCA2-deficient cancer cell xenograft mouse models . RP-2119 can be used for the research of cancer and homologous recombination-deficient cancers, including brca1/brca2-mutant cancers and shld2-mutant cancers .
loading...
    loading...
Cat. No.: HY-100862R
CAS No.: 1622262-55-8
Research Areas:  

Cancer

BRCA1-IN-2 (Standard) is the analytical standard of BRCA1-IN-2 (HY-100862). This product is intended for research and analytical applications. BRCA1-IN-2 (compound 15) is a cell-permeable protein-protein interaction (PPI) inhibitor for BRCA1 with an IC50 of 0.31 μM and a Kd of 0.3 μM, which shows antitumor activities via the disruption of BRCA1 (BRCT)2/protein interactions .
loading...
    loading...